A recent report published by Infinium Global Research on atrial
fibrillation market provides an in-depth analysis of segments and sub-segments in
the global as well as regional atrial fibrillation market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional atrial fibrillation market over the short term as well as
long term. The report is a comprehensive presentation of trends, forecast and
dollar values of the global atrial fibrillation market. According to the report,
the global atrial fibrillation market is projected to grow at a CAGR of 13.5%
over the forecast period of 2019-2025.
Atrial fibrillation (AF) is an irregular heartbeat that increases
the risk of stroke, heart, and other complications, such as discomfort or chest
pain. The treatment involves lifestyle changes, medication, and procedures such
as ablation, surgery, and cardioversion.
The factor such as aging population, rise in incidences of
obesity, hypertension, and diabetes resulted in different heart diseases, which
in turn, drives the global atrial fibrillation market. It is estimated that,
the prevalence of atrial fibrillation is higher in men than in women and higher
in whites than in blacks. In 2017, According to the centers for disease control
and prevention, 2.7–6.1 million people were suffering from atrial fibrillation
in the U.S. Another factor such as poor eating habits, sedentary occupations,
and various lifestyle illnesses may surge in cardiac issues, this in turns,
increasing atrial fibrillation diseases. However, the high cost associated with the
application of atrial fibrillation, devices are expected to hamper the market
growth. Furthermore, increasing research and development activities and
technological development is seen in the treatment and diagnoses of atrial
fibrillation is expected to create growth opportunities for the market in the
coming years.
Among the regions, Europe is anticipated to hold a major share in
the global atrial fibrillation market owing to the high adoption rate of
advanced technologies. Moreover, Germany has a higher role in this market, as
various catheter ablation procedures are performed in this region. Furthermore,
North America is accounted to hold the second position in this market over the
forecast period owing to due to well-developed healthcare infrastructures.
Moreover, countries such as the U.S. and Canada are a major contributor to
North America atrial fibrillation market. On the other hand, Asia-Pacific is
expected to be the fastest-growing region in this market throughout the
forecast period due to a rise in the prevalence of atrial fibrillation in the
geriatric population. Additionally, the improvement in healthcare
infrastructure is also helping the market growth in the Asia-Pacific region.
The report on global atrial fibrillation market covers segments
such as product type, end-user, and application. On the basis of product type,
the sub-markets include access devices, cardiac monitors, EP ablation
catheters, EP diagnostic catheters, EP mapping & recording systems, LAA
closure, and other products. On the basis of end-user, the sub-markets include
hospitals, electrophysiology labs, and ambulatory surgical center. On the basis
of application, the sub-markets include surgical, diagnostic, and EP ablation.
The report provides profiles of the companies in the market such
as CardioFocus, Inc., AtriCure, Koninklijke Philips N.V., Biotronik, MicroPort
Scientific, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories,
Johnson & Johnson, and Other Companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of atrial fibrillation market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.